Different Clinical Features of Amitraz Poisoning in Children

Basit Öğe Kaydı
dc.contributor.authorAtabek, Mehmet Emre
dc.contributor.authorAydın, K.
dc.contributor.authorErkul, I.
dc.date.accessioned2020-03-26T16:38:52Z
dc.date.available2020-03-26T16:38:52Z
dc.date.issued2002
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractObjective: To evaluate clinical experience of amitraz poisoning in children. Methods: In this study, the clinical and laboratory features of amitraz poisoning in 14 children are presented and compared with previous studies. Results: This study revealed that clinical manifestations of poisoning by oral and dermal routes appeared within 30-150 min, and that central nervous system (CNS) depression, which is the most important sign, improved within 6-24 hours and other signs within 24-72 hours. Unlike the findings in other studies, three severe cases in our study had reversible mydriasis and one of them required resuscitation because of cardiopulmonary arrest occurring as a result of serious respiratory depression. In addition, hepatic function test levels had increased in these three cases, and aspiration pneumonitis existed because of emesis in two of them. Conclusion: There is little information in the literature about dermal poisoning. The signs and symptoms of dermal poisoning were relatively mild compared with oral poisoning, and there were no topical signs. The classical signs of alpha(2)-adrenergic stimulation such as marked sinusal bradycardia and mydriasis as reported in many poisoning cases of animals have not been reported before our three severe cases among children.en_US
dc.identifier.citationAtabek, M. E., Aydın, K., Erkul, I., (2002). Different Clinical Features of Amitraz Poisoning in Children. Human & Experimental Toxicology, (21), 13-16.
dc.identifier.doi10.1191/0960327102ht207oaen_US
dc.identifier.endpage16en_US
dc.identifier.issn0960-3271en_US
dc.identifier.issue1en_US
dc.identifier.pmid12046718en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage13en_US
dc.identifier.urihttps://dx.doi.org/10.1191/0960327102ht207oa
dc.identifier.urihttps://hdl.handle.net/20.500.12395/17923
dc.identifier.volume21en_US
dc.identifier.wosWOS:000175702000003en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorAtabek, Mehmet Emre
dc.language.isoenen_US
dc.publisherArnold, Hodder Headline Plcen_US
dc.relation.ispartofHuman & Experimental Toxicologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectAdrenergic Agonistsen_US
dc.subjectamitrazen_US
dc.subjectmydriasisen_US
dc.subjectpoisoningen_US
dc.titleDifferent Clinical Features of Amitraz Poisoning in Childrenen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
emreatabek2002.pdf
Boyut:
143.65 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Çocuk Sağlığı ve Hastalıkları/Makale Koleksiyonu